CNI-Free Protocol in Kidney Transplant Recipients From Donors After Cardiac Death: Good Renal Function But High Incidence of Conversion to CNI

被引：0
|
作者：
Sanchez-Escuredo, A. [1 ]
Diekmann, F. [1 ]
Revuelta, I. [1 ]
Esforzado, N. [1 ]
Ricart, M. [1 ]
Cof, F. [1 ]
Torregrosa, V. [1 ]
Peri, L. [1 ]
Campistol, J. [1 ]
Oppenheimer, F. [1 ]
机构：
[1] Hosp Clin Barcelona, Barcelona, Spain
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2014年 / 14卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
C1847
引用
收藏
页码：594 / 595
页数：2
相关论文
共 50 条
  • [31] Pharmacokinetics (PK) and Pharmacodynamics (PD) of Belatacept in Kidney Transplant Recipients (KTR) after Conversion from CNI-Based Regimens
    Shen, J.
    Lee, S.
    Townsend, R.
    Zhou, Z.
    Roy, A.
    Thomas, D.
    Heifets, M.
    Masson, E.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 : 301 - 302
  • [32] Evolution of chronic renal dysfunction after conversion from calcineurin inhibitors (CNI) to mycophenolate mofetil monotherapy in liver transplant recipients
    Manrique, Alejandro
    Jimenez, Carlos
    Ortega, Patricia
    Abradelo, Manuel
    Meneu, Juan C.
    Gimeno, Alberto
    Perez, Baltasar
    Calvo, Jorge
    Donat, Maria
    Cambra, Felix
    Lopez, Rose M.
    Morales, Jose M.
    Moreno, Enrique
    TRANSPLANT INTERNATIONAL, 2007, 20 : 32 - 32
  • [33] MANDELA Study Results at 18 Months after Heart Transplantation: Superior renal function with CNI-free everolimus over standard CNI-based regimen- a randomized, multi-center trial in de novo heart transplant recipients
    Barten, Markus J.
    Hirt, Stephan W.
    Garbade, Jens
    Bara, Christoph
    Doesch, Andreas
    Knosalla, Christoph
    Grinninger, Carola
    Stypmann, Joerg
    Sieder, Christian
    Junge, Martina
    Schulz, Uwe
    TRANSPLANTATION, 2018, 102 : S362 - S362
  • [34] Early conversion to a CNI-free immunosuppression with SRL after renal transplantation-Long-term follow-up of a multicenter trial
    Andrassy, Joachim
    Guba, Markus
    Habicht, Antje
    Fischereder, Michael
    Pratschke, Johann
    Pascher, Andreas
    Heller, Katharina M.
    Banas, Bernhard
    Hakenberg, Oliver
    Vogel, Thomas
    Meiser, Bruno
    Dick, Andrea
    Werner, Jens
    Kauke, Teresa
    PLOS ONE, 2020, 15 (08):
  • [35] A Randomized, Open-Label Study To Compare the Safety and Efficacy of Conversion From a Calcineurin Inhibitor (CNI) to Sirolimus Versus Continued Use of a CNI in Cardiac Transplant Recipients with Mild to Moderate Renal Insufficiency
    Zuckermann, A.
    Keogh, A.
    Crespo-Leiro, M. G.
    Mancini, D.
    Gonzalez-Vilchez, F.
    Almenar, L.
    Brozena, S.
    Eisen, H.
    Tai, S. See
    Kashwaha, S.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2010, 29 (02): : S85 - S85
  • [36] CNI-TO-EVEROLIMUS CONVERSION IN RENAL TRANSPLANT RECIPIENTS WITH LOW IMMUNOLOGICAL RISK: IMPROVED OR MAINTAINED GFR AFTER 2.5 YEARS
    Gock, H.
    Mathew, M.
    NEPHROLOGY, 2013, 18 : 55 - 55
  • [37] Impact of mTOR Inhibitor Conversion Protocol on Renal Function in Cardiac Transplant Recipients
    Brink, H.
    Prucha, J. M.
    Bowman, S.
    Samson, K.
    Zolty, R.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2022, 41 (04): : S411 - S411
  • [38] Intragraft FOXP3+CD4 T cells and good graft function in pediatric renal transplant recipients receiving a calcineurin inhibitor (CNI) avoidance protocol
    Hancock, WW
    Meyers, K
    McDonald, R
    Ingelfinger, J
    Sayegh, MH
    Harmon, W
    AMERICAN JOURNAL OF TRANSPLANTATION, 2005, 5 : 545 - 545
  • [39] Prospective, Randomized Study of Conversion from Calcineurin Inhibitor (CNI)- to Belatacept (BELA)-Based Maintenance Immunosuppression in Renal Transplant Recipients
    Budde, K.
    Prashar, R.
    Haller, H.
    Rial, M.
    Kamar, N.
    Agarwal, A.
    de Fijter, J.
    Rostaing, L.
    Berger, S.
    Djamali, A.
    Leca, N.
    Allamassey, L.
    Gao, S.
    Polinsky, M.
    Vincenti, F.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2020, 20 : 437 - 438
  • [40] POST HOC ANALYSIS OF ZEUS AND HERAKLES, TWO PROSPECTIVE, OPEN-LABEL, MULTICENTER, RANDOMIZED TRIALS: ONSET AND PROGRESSION OF DIABETES IN KIDNEY TRANSPLANT RECIPIENTS ON CYCLOSPORINE STANDARD OR CONVERTED TO CNI-FREE OR CNI-LOW EVEROLIMUS REGIMEN
    Sommerer, C.
    Lehner, F.
    Budde, K.
    Arns, W.
    Hauser, I. A.
    Suwelack, B.
    Eisenberger, U.
    Reinke, P.
    Muehlfeld, A.
    Heller, K.
    Jacobi, J.
    Wolters, H.
    Porstner, M.
    Baeumer, D.
    Wuethrich, R. P.
    Guba, M.
    Kliem, V.
    Rath, T.
    Neumayer, H. -H.
    Zeier, M.
    TRANSPLANT INTERNATIONAL, 2014, 27 : 50 - 50
12345